
Bioventus BVS
€ 8.09
4.42%
Geschäftsbericht 2025
hinzugefügt 05.03.2026
Bioventus EV/EBITDA 2011-2026 | BVS
EV/EBITDA Jährlich Bioventus
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 26.4 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 26.4 | 26.4 | 26.4 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
27.4 | $ 117.17 | 1.83 % | $ 35.6 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 16.67 | 3.86 % | $ 888 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.6 | 5.63 % | $ 426 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 7.96 | 3.51 % | $ 1.02 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.43 | 4.38 % | $ 1.9 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 23.38 | 1.08 % | $ 649 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 177.66 | 1.14 % | $ 8.81 B | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.69 | 0.15 % | $ 279 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 497.88 | 0.88 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 194.98 | 2.83 % | $ 139 B | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
70.5 | $ 125.77 | 4.0 % | $ 20 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 511.92 | 3.14 % | $ 193 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.3 | 5.99 % | $ 463 M | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.71 | -0.74 % | $ 61.9 M | ||
|
Guardant Health
GH
|
-28.8 | $ 81.33 | 3.47 % | $ 10.2 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.79 | 3.72 % | $ 90.5 K | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 50.08 | 4.52 % | $ 3 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.09 | -1.88 % | $ 4.8 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 28.56 | 0.88 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 110.47 | 3.43 % | $ 9.11 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.66 | 0.05 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 264.01 | 1.18 % | $ 22 B | ||
|
Natera
NTRA
|
-19.5 | $ 201.61 | 4.44 % | $ 19.8 B | ||
|
Celcuity
CELC
|
-2.38 | $ 119.02 | 1.6 % | $ 5.57 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 81.19 | 0.74 % | $ 5.48 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
24.6 | $ 322.55 | 0.75 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 191.19 | -0.17 % | $ 21.2 B |